| # | Title | Journal | Year | Citations |
|---|
| 1 | Gestational diabetes mellitus | Nature Reviews Disease Primers | 2019 | 811 |
| 2 | Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients | Diabetes | 2001 | 796 |
| 3 | Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients | Journal of Clinical Endocrinology and Metabolism | 2001 | 767 |
| 4 | The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion: Effects on -Cell Sensitivity in Type 2 and Nondiabetic Subjects | Diabetes | 2003 | 513 |
| 5 | Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects | Regulatory Peptides | 2003 | 360 |
| 6 | Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery | Lancet Diabetes and Endocrinology,the | 2014 | 248 |
| 7 | Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes | Diabetes Care | 2011 | 233 |
| 8 | Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood | Human Molecular Genetics | 2015 | 223 |
| 9 | Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists | Diabetes, Obesity and Metabolism | 2016 | 211 |
| 10 | Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass | International Journal of Obesity | 2013 | 209 |
| 11 | The Treatment of Obese Pregnant Women (TOP) study: a randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women | American Journal of Obstetrics and Gynecology | 2014 | 186 |
| 12 | YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis | Inflammation Research | 2006 | 185 |
| 13 | An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future | Diabetes, Obesity and Metabolism | 2011 | 175 |
| 14 | Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial | Lancet, The | 2008 | 173 |
| 15 | The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes | Diabetes Care | 2013 | 172 |
| 16 | Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus | Diabetologia | 2007 | 165 |
| 17 | YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance | Inflammation Research | 2006 | 162 |
| 18 | Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? | Diabetologia | 2014 | 156 |
| 19 | Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity | Diabetes, Obesity and Metabolism | 2012 | 153 |
| 20 | Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux‐en‐Y gastric bypass | Neurogastroenterology and Motility | 2013 | 150 |
| 21 | Incretin-Based Therapies | Diabetes Care | 2009 | 143 |
| 22 | Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function | Diabetes Care | 2011 | 143 |
| 23 | Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes | Journal of Clinical Endocrinology and Metabolism | 2001 | 141 |
| 24 | Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study | European Journal of Endocrinology | 2009 | 133 |
| 25 | Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial | Lancet Diabetes and Endocrinology,the | 2016 | 127 |
| 26 | Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults | Journal of Neuro-Oncology | 2011 | 126 |
| 27 | The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men | Diabetologia | 2009 | 123 |
| 28 | Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction | European Journal of Endocrinology | 1993 | 121 |
| 29 | Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia | Diabetologia | 1998 | 118 |
| 30 | YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria | Diabetes Care | 2009 | 117 |
| 31 | The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone | Metabolism: Clinical and Experimental | 1994 | 114 |
| 32 | Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules | Clinical Endocrinology | 1999 | 111 |
| 33 | Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics) – preclinical and clinical results | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 108 |
| 34 | Bone Mineral Metabolism, Bone Mineral Density, and Body Composition in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency | International Journal of Gastrointestinal Cancer | 2000 | 107 |
| 35 | Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion | Diabetes Care | 2010 | 105 |
| 36 | Twelve weeks treatment with the DPP‐4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non‐glucose induced insulin secretion in patients with type 2 diabetes mellitus | Diabetes, Obesity and Metabolism | 2010 | 104 |
| 37 | IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population | European Journal of Endocrinology | 2009 | 103 |
| 38 | The Effect of Glucagon-Like Peptide I (GLP-I) on Glucose Elimination in Healthy Subjects Depends on the Pancreatic Glucoregulatory Hormones | Diabetes | 1996 | 102 |
| 39 | Obesity, growth hormone and weight loss | Molecular and Cellular Endocrinology | 2010 | 101 |
| 40 | Radioiodine Therapy for Multinodular Toxic Goiter | Archives of Internal Medicine | 1999 | 98 |
| 41 | Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction | JAMA Cardiology | 2021 | 95 |
| 42 | Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study | Diabetes Care | 2015 | 91 |
| 43 | Specificity and sensitivity of commercially available assays for glucagon‐like peptide‐1 (GLP‐1): implications for GLP‐1 measurements in clinical studies | Diabetes, Obesity and Metabolism | 2014 | 85 |
| 44 | Pleiotropic Effects of GIP on Islet Function Involve Osteopontin | Diabetes | 2011 | 83 |
| 45 | Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery | Cell Systems | 2018 | 80 |
| 46 | Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial | Lancet Diabetes and Endocrinology,the | 2021 | 80 |
| 47 | Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment – Data Using a Blind, Randomized, Clinical Study | European Thyroid Journal | 2017 | 79 |
| 48 | Insulin Signal Transduction in Skeletal Muscle From Glucose-Intolerant Relatives With Type 2 Diabetes | Diabetes | 2001 | 77 |
| 49 | Hypoglycaemia during pregnancy in women with Type 1 diabetes | Diabetic Medicine | 2012 | 76 |
| 50 | Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance | Diabetes | 2013 | 75 |
